Clinical Trial Evaluating Gastrointestinal Damage Following Administration PL3100 or Naproxen in At-Risk Adults

Clinical trial NCT01139190 · COMPLETED

Trial details

NCT number: NCT01139190
Sponsor: PLx Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastroduodenal Ulcerations Erosion

Start date: 2010-07-01
Primary completion: 2010-12-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.